Ajovy and Clopidogrel drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ajovy (fremanezumab-vfrm) and Clopidogrel (clopidogrel). Common drug interactions include basal ganglia infarction among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Ajovy and Clopidogrel. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Ajovy?
Ajovy has active ingredients of fremanezumab-vfrm. eHealthMe is studying from 8,834 Ajovy users. Check the latest studies of Ajovy.
What is Clopidogrel?
Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 92,160 Clopidogrel users. Check the latest studies of Clopidogrel.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who take Ajovy and Clopidogrel together, and have interactions are studied.

What are the common drug interactions of Ajovy and Clopidogrel, by gender? *:
female:
- Basal ganglia infarction (disruption of the blood flow in the small blood vessels in the white matter of the cerebral cortex)
- Basal ganglia stroke (basal ganglia stroke occurs is when the flow of blood is blocked from the middle of the brain)
- Malignant melanoma (skin cancer rises from melancytes)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Retinal dystrophy (progressive weakness and wasting of the retina)
- Contusion (a type of hematoma of tissue in which capillaries)
- Age-related macular degeneration
- Drug ineffective
- Dysstasia (difficulty in standing)
- Hypersomnia (excessive daytime sleepiness (eds))
male:
- Drug ineffective
- Blood iron decreased
- Hallucination (an experience involving the perception of something not present)
- Hypoxia (low oxygen in tissues)
- Intervertebral disc protrusion (spinal disc protrusion)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Restless legs syndrome (a powerful urge to move your legs)
- Road traffic accident
- Sedation
- Somnambulism (sleep walking)
What are the common drug interactions of Ajovy and Clopidogrel, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Malignant melanoma (skin cancer rises from melancytes)
- Dysstasia (difficulty in standing)
- Hypersomnia (excessive daytime sleepiness (eds))
- Weight increased
50-59:
n/a
60+:
- Drug ineffective
- Basal ganglia infarction (disruption of the blood flow in the small blood vessels in the white matter of the cerebral cortex)
- Haemoglobin decreased
- Injection site pain
- Road traffic accident
- Basal ganglia stroke (basal ganglia stroke occurs is when the flow of blood is blocked from the middle of the brain)
- Nervous system disorder (a general class of medical conditions affecting the nervous system)
- Retinal dystrophy (progressive weakness and wasting of the retina)
- Age-related macular degeneration
- Blood iron decreased
What are the existing conditions these people have? *
- Migraine (headache): 11 people, 84.62%
- Asthma: 3 people, 23.08%
- Urinary Tract Infection: 2 people, 15.38%
- High Blood Pressure: 2 people, 15.38%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 15.38%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 15.38%
- Cystitis Interstitial (unknown cause characterized by bladder pain): 2 people, 15.38%
- Depression: 2 people, 15.38%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 15.38%
- Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 15.38%
* Approximation only. Some reports may have incomplete information.
Do you take Ajovy and Clopidogrel?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ajovy (8,834 reports)
- Clopidogrel (92,160 reports)
Browse all drug interactions of Ajovy and Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ajovy:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Clopidogrel:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ajovy and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Clopidogrel and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
- Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
- Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
- Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on fremanezumab-vfrm and clopidogrel (the active ingredients of Ajovy and Clopidogrel, respectively), and Ajovy and Clopidogrel (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cyclophosphamide cause Neutrophil Count Abnormal? - 3 seconds ago
- Asthma and Oral Candidiasis - 5 seconds ago
- Allegra Allergy and Xyrem drug interactions for women aged 50-59 - 17 seconds ago
- Could Pyrazinamide cause Nephrotic Syndrome? - a minute ago
- Could Pegasys cause Proctalgia? - a minute ago
- Could Hydroxocobalamin cause Blood Alkaline Phosphatase Increased? - a minute ago
- High Blood Cholesterol and Papule - a minute ago
- Pain and Anhedonia - a minute ago
- Could Asa cause Infusion Site Swelling? - a minute ago
- Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride vs. Benadryl, side effect and effectiveness comparison - a minute ago